Pharmaceutical Independence Long-Term Readiness Reform Act
Latest action · Nov 8, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 17, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Independence Long-Term Readiness Reform Act
This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.
Cosponsors 19
Members who signed on, in the order they did. Signatures ran from Oct 17, 2019 to May 19, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MO | Vicky Hartzler | Original | Oct 17, 2019 |
| D-TX | Veronica Escobar | Nov 8, 2019 | |
| R-MT | Greg Gianforte | Feb 14, 2020 | |
| R-PA | Brian K. Fitzpatrick | Mar 2, 2020 | |
| R-NY | Elise M. Stefanik | Apr 17, 2020 | |
| D-TX | Sheila Jackson Lee | Apr 21, 2020 | |
| R-NE | Don Bacon | Apr 28, 2020 | |
| R-MS | Michael Guest | Apr 28, 2020 | |
| R-MN | Pete Stauber | May 5, 2020 | |
| R-TX | Ron Wright | May 5, 2020 | |
| R-CO | Scott R. Tipton | May 5, 2020 | |
| R-FL | Bill Posey | May 8, 2020 | |
| R-NJ | Christopher H. Smith | May 8, 2020 | |
| D-HI | Ed Case | May 8, 2020 | |
| D-TN | Steve Cohen | May 8, 2020 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Armed Services Committee | Referred Oct 17, 2019 |
| House | Veterans' Affairs Committee | Referred Oct 17, 2019 |
| Health Subcommittee | Referred Nov 8, 2019 | |
| House | Financial Services Committee | Referred Oct 17, 2019 |
Actions 4
Everything that happened, newest first.
- Nov 8, 2019Referred to the Subcommittee on Health.
- Oct 17, 2019Introduced in House
- Oct 17, 2019Sponsor introductory remarks on measure. (CR E1297-1298)
- Oct 17, 2019Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House · Extensions | Debate and remarks E1297Lists H8227H.R. 4710–4732 | John Garamendi D-CA | Oct 17, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 164, October 17, 2019, page H8227.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| H.A.S.C. No. 116-84 | DEPARTMENT OF DEFENSE COVID-19 RESPONSE TO DEFENSE INDUSTRIAL BASE CHALLENGES85 pages | Armed Services Committee | Jun 10, 2020 |
| S. Hrg. 116-490 | COVID-19 AND BEYOND: OVERSIGHT OF THE FDA'S FOREIGN DRUG MANUFACTURING INSPECTION PROCESS231 pages | Finance Committee | Jun 2, 2020 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46304 | COVID-19: China Medical Supply Chains and Broader Trade Issues | Report | Dec 23, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To direct the Secretary of Defense to include in each national defense strategy steps to strengthen the United States industrial base and to assure an uninterrupted supply of medicines, and for other purposes.
- Short Title(s) as Introduced
- Pharmaceutical Independence Long-Term Readiness Reform Act
Subjects
Assigned by the Library of Congress. Policy area: Armed Forces and National Security.
- Armed Forces and National Security
- Buy American requirements
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Health technology, devices, supplies
- Immunology and vaccination
- Industrial policy and productivity
- Manufacturing
- Military medicine
- Military operations and strategy
- Military procurement, research, weapons development
- Military readiness
- Prescription drugs
- Public contracts and procurement
- Strategic materials and reserves
- Veterans' medical care
Text 1
Each version as it was printed, newest first.
- Oct 17, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.